A hypothesis In the last 20 years, many works either in vitro or using genetically modified animal models have agreed that A somehow contributes to the progression of AD, making it a prime target for various therapeutic interventions
Statins could reduce the synthesis of cholesterol, thus increasing the number and activity of low-density lipoprotein (LDL) receptors on the membrane of liver cells and enhancing the clearance of plasma cholesterol [1, 2]
When looking at the intersections between two or more groups, thymine was enriched in all the groups apart from T4
[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Tomer R, Patiyal S, Dhall A, Raghava GPS
The peptide has been administered at doses far exceeding those used therapeutically without significant adverse effects
2013;57(2):214-219 Rooyackers O